Your WhatsApp is full of SpaceX and “biggest IPO ever” talk, but almost nobody is showing you what happens two years after listing day. In this Bedok‑to‑Jurong kopi chat, I walk through why most IPOs underperform the boring index, and why that gap matters a lot more than the first‑day pop. We use names like SpaceX, JustCo and NTT DC REIT to show how insiders sell at peak hype while CPF and SRS investors get stuck holding the long‑run risk. If you are managing a dividend portfolio and thinking “maybe this IPO is different”, this episode is the uncomfortable forensic check you need before you follow the crowd.
Key takeaways:
Why IPOs are designed as exits for founders and early funds, not CPF investors
What long‑run IPO data really says about buy‑and‑hold for Singapore households
How SpaceX, JustCo and NTT DC REIT show the same hype‑then‑lag pattern
The simple discipline that keeps your SRS focused on compounding, not roadshows
Why “missing the pop” is less dangerous than quietly lagging the STI for years
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
